Title
Administration d'aripiprazole dans le traitement des troubles du spectre autistique (TSA)
Subtitle
Aripiprazole for Autism Spectrum Disorders (ASD)
Author
Lauren E. Hirsch; Tamara Pringsheim
Summary
This online article, in French, summarizes a research review conducted to determine whether aripiprazole, an antipsychotic medication, is an effective treatment for severe behavior problems in people on the autism spectrum. The article concludes that evidence suggests aripiprazole can improve behavior issues in the short term, but side effects such as weight gain and involuntary tremors are possible.
The authors note that more research is needed to determine whether aripiprazole is effective in the long term. The English version notes that one study showed similar long-term relapse rates in the placebo and treatment groups, suggesting that periodic re-evaluation of the medications' effectiveness may be necessary.
This resource is available in English, Croatian, French, German, Spanish, and Tamil.
Cochrane is a "global independent network of researchers, professionals, patients, carers, and people interested in health." [Website] The network reviews evidence about health treatments.
Language
French
Subjects
Therapies
Evaluating Research & Information
Publisher
Cochrane
DateModified
12/30/2022 7:36 PM EST